Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
UBS
Teva
Chubb
Dow
Covington
Harvard Business School
Baxter
AstraZeneca
Colorcon

Generated: August 23, 2017

DrugPatentWatch Database Preview

Vecuronium bromide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for vecuronium bromide and what is the scope of vecuronium bromide freedom to operate?

Vecuronium bromide
is the generic ingredient in two branded drugs marketed by Sun Pharma Global, West-ward Pharms Int, Watson Labs, Mylan Labs Ltd, Hospira, Sagent Pharms, Organon Usa Inc, Teva Pharms Usa, and Gland Pharma Ltd, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for vecuronium bromide. Twelve suppliers are listed for this compound.

Summary for Generic Name: vecuronium bromide

Tradenames:2
Patents:0
Applicants:9
NDAs:11
Drug Master File Entries: see list6
Suppliers / Packagers: see list12
Bulk Api Vendors: see list47
Clinical Trials: see list320
Patent Applications: see list1,594
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:vecuronium bromide at DailyMed

Pharmacology for Ingredient: vecuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION205390-002May 26, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION075549-001Jun 13, 2000APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION079001-002Jun 17, 2009APRXNoYes► Subscribe► Subscribe► Subscribe
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-002Apr 30, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-003Jan 3, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION075218-001Aug 23, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION078274-002Dec 29, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma Ltd
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION205390-001May 26, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION075558-001Sep 11, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
VECURONIUM BROMIDE
vecuronium bromide
INJECTABLE;INJECTION090243-002May 11, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: vecuronium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-002Apr 30, 1984► Subscribe► Subscribe
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-003Jan 3, 1992► Subscribe► Subscribe
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-002Apr 30, 1984► Subscribe► Subscribe
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-002Apr 30, 1984► Subscribe► Subscribe
Organon Usa Inc
NORCURON
vecuronium bromide
INJECTABLE;INJECTION018776-003Jan 3, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Merck
Novartis
Fuji
Chubb
Accenture
Citi
Chinese Patent Office
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot